Healthy Skepticism Library item: 3814

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Is Yasmin a "truly different" pill?
Drug Ther Bull 2002; 40:(8):57-9
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12216337

Abstract:

A combined oral contraceptive (COC) containing the progestogen drospirenone (pronounced dro-spi-re-known) plus the oestrogen ethinylestradiol ([symbol: see text] Yasmin—Schering Health Care) is now available in the UK. Company advertising claims that Yasmin is “truly different”, as reliable and safe as other COCs and is “the pill for well-being”, with “no associated weight gain” and “a demonstrable positive effect” on premenstrual symptoms and skin condition. Such claims have also appeared in the lay media. Are they justified?

Keywords:
*analysis/United Kingdom/combination drugs/ contraception/Schering/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: BREAST FEEDING AND CONTRACEPTION/PROMOTION DISGUISED: PRESS CONFERENCES AND PRESS COVERAGE